首页> 外国专利> PHARMACEUTICAL COMPOSITIONS CONTAINING BAFF LIGAND OR AN AGENT INHIBITING SAID LIGAND, FOR THE USE TO STIMULATION AND INHIBITION OF B-LYMPHOCYTES AND IMMUNOGLOBULINE SECRETION

PHARMACEUTICAL COMPOSITIONS CONTAINING BAFF LIGAND OR AN AGENT INHIBITING SAID LIGAND, FOR THE USE TO STIMULATION AND INHIBITION OF B-LYMPHOCYTES AND IMMUNOGLOBULINE SECRETION

机译:包含BAFF配体或抑制所述配体的药物的药物组合物,用于刺激和抑制B淋巴细胞和免疫球蛋白分泌

摘要

Stimulating B-cell growth, immunoglobulin production, or dendritic cell-induced B-cell growth and maturation, or co-stimulating B-cell growth and immunoglobulin production, comprising administering a composition containing the tumor necrosis factor family B cell activating factor (BAFF) or its active fragment, and optionally an anti-Micro antibody, a CD40 ligand or an anti-CD40 ligand, is new. An independent claim is also included for a method of inhibiting B-cell growth, immunoglobulin production, or dendritic cell-induced B-cell growth, or co-inhibiting B-cell growth and immunoglobulin production, comprising administering an anti-BAFF ligand molecule, a recombinant, inoperative BAFF ligand molecule, an antibody specific for BAFF ligand, active fragments of the molecules, or an antibody specific for BAFF ligand receptor, or an epitope of it. ACTIVITY : Immunosuppressive; virucide; antiinflammatory; hypotensive; nephrotropic; cardiant; cytostatic. No biological data is given. MECHANISM OF ACTION : B-cell growth and/or immunoglobulin production stimulators or inhibitors.
机译:刺激B细胞生长,免疫球蛋白产生或树突细胞诱导的B细胞生长和成熟,或共同刺激B细胞生长和免疫球蛋白产生,包括给予包含肿瘤坏死因子家族B细胞活化因子(BAFF)的组合物或其活性片段,以及任选的抗微抗体,CD40配体或抗CD40配体是新的。还包括抑制B细胞生长,免疫球蛋白产生或树突状细胞诱导的B细胞生长,或共同抑制B细胞生长和免疫球蛋白产生的方法的独立权利要求,包括给予抗BAFF配体分子,重组的,无效的BAFF配体分子,对BAFF配体特异的抗体,分子的活性片段或对BAFF配体受体特异的抗体或其表位。活动:免疫抑制;杀病毒剂消炎(药;低血压嗜肾坚强抑制细胞生长的。没有给出生物学数据。作用机理:B细胞生长和/或免疫球蛋白产生刺激剂或抑制剂。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号